R. Gillet et al., The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents, ONCOGENE, 19(31), 2000, pp. 3498-3507
To analyse the effect of p53 on liver tumor development, we generated trans
genic mice overexpressing wild-type p53 in the liver and crossed them with
transgenic mice in which the expression of the SV40 large T antigen (TAg) i
nduces hepatic tumors. Remarkably, whereas preneoplastic TAg liver exhibite
d anisocaryosis and anisocytosis, TAg/p53 liver never presented any dysplas
tic cells. Moreover, whereas expression of p53 did not affect hepatic devel
opment, its constitutive expression in tumorigenic livers resulted in a sig
nificantly enhanced apoptosis once nodules had appeared. In contrast, p53 o
verexpression did not modify the elevated proliferation of TAg-transformed
hepatocytes and had no effect on hepatocarcinoma progression. In vitro anal
ysis of primary hepatocytes exposed to various genotoxic agents showed that
p53 failed to sensitize normal or TAg-transformed hepatocytes to apoptosis
, except when high doses of doxorubicin, UV-B and UV-C radiation were used.
Our results confirmed that the hepatocyte cell type is very resistant to g
enotoxic agents and showed that constitutive expression of p53 failed to im
prove their responsiveness. In addition, our results showed that suppressio
n of dysplastic cells, probably by restoring normal cytokinesis and karyoki
nesis, and enhancement of apoptosis by means of p53 overexpression were ins
ufficient to counteract or delay the TAg-induced liver tumoral progression.